Real-world treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in Germany: Results of a retrospective observational study (CONVINCE)

被引：0
|
作者：
Machtens, Stefan [1 ]
Schlack, Katrin [2 ]
Kubin, Thomas [3 ]
Ruhnke, Markus [4 ]
Schulte, Clemens [5 ]
Eisen, Anna [6 ]
Osowski, Ulrike [7 ]
Guenther, Silke [8 ]
Kearney, Mairead [8 ]
Lipp, Rainer [6 ]
Schmitz, Stephan H. [9 ]
机构：
[1] GFO Hosp Rhein Berg, Marien Hosp, Dept Urol, Bergisch Gladbach, Germany
[2] Univ Hosp Muenster, Dept Urol, Munster, Germany
[3] Clin Sudostbayern AG, Dept Hematol Oncol & Palliat Care, Clin Traunstein, Traunstein, Germany
[4] Helios Clin Aue, Clin Hematol Oncol & Palliat Med, Aue, Germany
[5] Practice Hematol & Oncol, Dortmund, Germany
[6] GermanOncol GmbH, Hamburg, Germany
[7] Merck Healthcare Germany GmbH, Merck KGaA, Weiterstadt, Germany
[8] Healthcare Business Merck KGaA, Darmstadt, Germany
[9] Med Care Ctr Oncol & Hematol, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [31] TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER IN ENGLAND: RESULTS OF A LONGITUDINAL OBSERVATIONAL COHORT STUDY
    Kearney, M.
    Knott, C.
    Lamy, F. X.
    Harnett, J.
    Amin, A.
    Verpillat, P.
    VALUE IN HEALTH, 2020, 23 : S483 - S483
  • [32] Real-world (RW) systemic treatment patterns and clinical outcomes in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) patients (pts).
    Thao Vo
    Boyd, Marley
    Espirito, Janet L.
    Gumuscu, Burak
    Chirovsky, Diana Romana
    Robert, Nicholas J.
    Swaby, Ramona F.
    Zhou, Wei
    Cowey, Charles Lance
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Treatment patterns and clinical outcomes in patients with metastatic urothelial carcinoma in England: A retrospective observational study.
    Shiri, Tinevimbo
    Nievaart, Max
    Gill, Simran
    Perkin, William
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [35] Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States
    Geynisman, Daniel M.
    Broughton, Edward
    Hao, Yi
    Zhang, Ying
    Le, Trong
    Huo, Stephen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 195.e1 - 195.e11
  • [36] Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
    Kita, Yuki
    Otsuka, Hikari
    Ito, Katsuhiro
    Hara, Takuto
    Shimura, Soichiro
    Kawahara, Takashi
    Kato, Minoru
    Kanamaru, Sojun
    Inoue, Koji
    Ito, Hiroki
    Igarashi, Atsushi
    Sazuka, Tomokazu
    Takamatsu, Dai
    Hashimoto, Kohei
    Abe, Takashige
    Naito, Sei
    Matsui, Yoshiyuki
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (05) : 552 - 559
  • [37] A retrospective cohort study to monitor real-world safety in patients with locally advanced or metastatic urothelial carcinoma (LA/mUC) treated with sacituzumab govitecan (SG) in the United States.
    Parikh, Mamta
    Boateng, Freda
    Eng, Susan
    Sierecki, Mitch
    Chen, Fangfei
    Brockman, Jane Michelle
    Ghazi, Youssef
    Ng, Leslie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 608 - 608
  • [38] Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)
    Barthelemy, P.
    Thibault, C.
    Voog, E.
    Eymard, J-C.
    Ravaud, A.
    Flechon, A.
    Jaillon, C. Abraham
    Hilgers, W.
    Le Moulec, S.
    Chasseray, M.
    Pouessel, D.
    Amela, Y. E.
    Lorgis, V.
    Nicolas, E.
    Kazan, E.
    Denechere, G.
    Solbes, M-N.
    Lambert, P.
    Loriot, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1341 - S1342
  • [39] Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain
    Puente, Javier
    Pinto, Alvaro
    Mendez-Vidal, Maria Jose
    del Muro, Xavier Garcia
    Maroto, Pablo
    Vazquez, Sergio
    Luque-Caro, Raquel
    Anido, Urbano
    Strunz-McKendry, Torsten
    Upadhyay, Anil
    Montes, Jose
    Nunez, Aurora Ortiz
    Portela, Judit Gonzalez
    Castellano, Daniel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 2232 - 2240
  • [40] A Real-World Data Study to Evaluate Treatment Patterns, Clinical Characteristics and Survival Outcomes for First-and Second-Line Treatment in Locally Advanced and Metastatic Urothelial Cancer Patients in Germany
    Niegisch, Guenter
    Gerullis, Holger
    Lin, Shih-Wen
    Pavlova, Julie
    Gondos, Adam
    Rudolph, Anja
    Haas, Gabriele
    Hennies, Nora
    Kramer, Mario W.
    JOURNAL OF CANCER, 2018, 9 (08): : 1337 - 1348
12345